Barclays PLC Buys New Stake in Protara Therapeutics, Inc. (NASDAQ:TARA)

Barclays PLC bought a new position in shares of Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 93,239 shares of the company’s stock, valued at approximately $492,000. Several other hedge funds and other institutional investors also […]

Leave a Reply

Your email address will not be published.

Previous post Barclays PLC Buys 11,876 Shares of Eastman Kodak (NYSE:KODK)
Next post National Research Co. (NASDAQ:NRC) Shares Sold by Barclays PLC